Expertise in
14
conditions

Marco C. Romanelli

Pisa, IT 
Expertise in
14
conditions
Pisa, IT 
OverviewLocationsClinical Research

Overview

Marco Romanelli practices in Pisa, Italy. Romanelli is highly rated in 14 conditions, according to our data. Their top areas of expertise are Pyoderma Gangrenosum, Hidradenitis Suppurativa, Psoriasis, and Plaque Psoriasis.

Their clinical research consists of co-authoring 255 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Pisa, Italy
Other Locations
Milan, 20097, Italy
Rome, 56126, Italy
Florence, 50127, Italy
Siena, Italy
Bari, Italy
Livorno, Italy
Lucca, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Multi-centre, Randomized Controlled, Prospective Study on the Speed of Healing, Life Quality and Cost-effectiveness of the Treatment With the Blue Light Medical Device EmoLED vs a Standard Treatment for Leg Ulcers (L.U.C.E. Study)
Multi-centre, Randomized Controlled, Prospective Study on the Speed of Healing, Life Quality and Cost-effectiveness of the Treatment With the Blue Light Medical Device EmoLED vs a Standard Treatment for Leg Ulcers (L.U.C.E. Study)
Enrollment Status: Completed
Publish Date: May 09, 2025
Intervention Type: Procedure, Device
Study Phase: Not Applicable
A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7
Enrollment Status: Completed
Publish Date: August 11, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

255 Total Publications

Efficacy and safety of a medical device based on hyaluronic acid and amino acids for the topical treatment of hard-to-heal skin ulcers: a pilot clinical trial.
Efficacy and safety of a medical device based on hyaluronic acid and amino acids for the topical treatment of hard-to-heal skin ulcers: a pilot clinical trial.
Journal: Journal of wound care
Published: September 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Romanelli's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 39 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile